在患有家族局部脂质缩症的患者心脏几何和功能的心声图学变化
Minna Moreira Dias Romano1, André Timóteo Sapalo1, Natália Rossin Guidorizzi1
1Centro de Cardiologia da Faculdade de Medicina de Ribeirão Preto - Universidade de São Paulo (USP), São Paulo - Brasil.
Arquivos brasileiros de cardiologia
|June 26, 2024
概括
患有部分脂质缩症 (PL) 的患者表现出心脏变化,包括左心室缩和腹功能障碍,独立于血压. 这些发现凸显了PL对心脏的影响.
科学领域:
- 心脏病学 心脏病学
- 遗传学 是一个遗传学.
- 内部医学 内部医学
背景情况:
- 部分脂质变 (PL) 的心肌病并没有得到充分的记录.
- 局部脂质缩是一种罕见的疾病,其特点是选择性损失皮下脂肪组织.
研究的目的:
- 为了研究和描述家族局部脂质缩症患者的心脏形态和功能.
- 评估心声回声学参数及其与PL诊断的关系.
主要方法:
- 展望评估29名家族局部脂质疏松症患者和17名对照人群,使用跨胸腔心脏回声学.
- 斑点跟踪回声心脏图被用来测量全球纵向应变 (GLS).
- 回归模型分析了回声心脏学变量,考虑了缩血压 (SBP) 的影响.
主要成果:
- 部分脂质疏松症患者的SBP较高,左心房扩大,左心室质量增加,腹功能受损 (E'降低和E/E'比率升高).
- 左心室喷射分数和全球纵向应变在各组之间没有显著差异.
- 左心房大小,后壁厚度和腹筋参数与PL诊断相关,独立于SBP.
结论:
- 局部脂质缩与左心室缩,左心房扩大和腹功能障碍有关.
- 在PL中,心脏结构和功能发生了显著的改变,即使保留了射出分数和GLS.
- 心声图的发现与PL诊断有关,而不依赖于缩血压.
相关概念视频
Imaging Studies for Cardiovascular System I:Echocardiography
1.0K
Cardiac imaging studies encompass a wide range of noninvasive and minimally invasive techniques designed to visualize the heart's structure and function in detail. One such technique is echocardiography, which uses high-frequency ultrasound waves to produce detailed images of the heart, known as echocardiograms.
Indications: Echocardiography is utilized to diagnose heart failure, valve disorders, and myocardial infarction. It also assesses cardiac structures' size, shape, and motion,...
Indications: Echocardiography is utilized to diagnose heart failure, valve disorders, and myocardial infarction. It also assesses cardiac structures' size, shape, and motion,...
1.0K
Mitral Stenosis II: Clinical features and Diagnostic Tests
557
Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
557
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
1.2K
Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
1.2K
Heart Failure II: Pathophysiology
1.9K
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.9K
Cardiomyopathy II: Dilated Cardiomyopathy
790
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
790
Cardiomyopathy III: Hypertrophic Cardiomyopathy
805
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
805


